Article
Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.
Journal of virology - 1 Mar 2005
Chambers Thomas J, Fan Xiaofeng, Droll Deborah A, Hembrador Edgardo, Slater Tiffany, Nickells Michael W, Dustin Lynn B, Dibisceglie Adrian M
Abstract excerpt
A series of 29 patients undergoing treatment for chronic hepatitis C virus (HCV) genotype 1 infection with pegylated alpha-2a interferon plus ribavirin were studied for patterns of response to antiviral therapy and viral quasispecies evolution. All patients were treatment naive and had chronic inflammation and fibrosis on biopsy. As part of an analysis of pretreatment variables that might affect the outcome of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
